Mechanisms and regulation of the gene-expression response to sepsis

Pediatrics

Volumn 125, Issue 6, 2010, Pages 1248-1258

  Cornell, Timothy T ^a   Wynn, James ^b   Shanley, Thomas P ^a   Wheeler, Derek S ^c   Wong, Hector R ^c  

^a UNIVERSITY OF MICHIGAN   (United States)

^b DUKE CHILDREN S HOSPITAL   (United States)

^c CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

Author keywords

Epigenetics; Genetics; Immunity; Sepsis; Septic shock

Indexed keywords

CD14 ANTIGEN; ELASTASE; ELASTASE II; GRANZYME B; HEAT SHOCK PROTEIN 70; HEAT SHOCK PROTEIN 70 1B; INTERLEUKIN 1; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 12P35; INTERLEUKIN 12P40; INTERLEUKIN 1ALPHA; INTERLEUKIN 6; INTERLEUKIN 8; LACTOFERRIN; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MESSENGER RNA; MYELOID DIFFERENTIATION FACTOR 88; NEUTROPHIL COLLAGENASE; NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN; OROSOMUCOID; OROSOMUCOID 1; PROTEIN MD 2; RESISTIN; T LYMPHOCYTE RECEPTOR; THROMBOSPONDIN 1; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; ZINC;

ADAPTIVE IMMUNITY; ANTIGEN PRESENTATION; BLOOD CLOTTING; CHILD; CYTOKINE PRODUCTION; DISEASE PREDISPOSITION; DNA METHYLATION; DOWN REGULATION; DRUG TARGETING; EPIGENETICS; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE REPRESSION; GENE SEQUENCE; GENETIC ASSOCIATION; GENETIC TRANSCRIPTION; GENOMICS; HEREDITY; HOMEOSTASIS; HUMAN; IMMUNE RESPONSE; INFLAMMATION; MENINGOCOCCEMIA; MICROARRAY ANALYSIS; NONHUMAN; NUCLEOTIDE SEQUENCE; OLIGONUCLEOTIDE PROBE; PATHOGENESIS; PHAGOCYTOSIS; PREDICTION; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN MODIFICATION; PROTEIN PROCESSING; REVIEW; RNA TRANSLATION; ROBOTICS; SEPSIS; SEPTIC SHOCK; SIGNAL TRANSDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; TRANSCRIPTION INITIATION; UPREGULATION; VALIDATION STUDY;

EPIGENESIS, GENETIC; GENE EXPRESSION; HUMANS; POLYMORPHISM, SINGLE NUCLEOTIDE; SENSITIVITY AND SPECIFICITY; SEPSIS; SHOCK, SEPTIC; TOLL-LIKE RECEPTORS;

EID: 77953075386     PISSN: 00314005     EISSN: 10984275     Source Type: Journal    
DOI: 10.1542/peds.2009-3274     Document Type: Review

References (88)

1. Wong HR, Shanley TP. Genetic Basis of Acute Lung Injury. New York, NY: Saunders; 2007
2. Heller MJ. DNA microarray technology: devices, systems, and applications. Annu Rev Biomed Eng. 2002;4:129-153 (Pubitemid 35217417)
3. Cooke GS, Hill AV. Genetics of susceptibility to human infectious disease. Nat Rev Genet. 2001;2(12):967-977 (Pubitemid 33691093)
4. Sørensen TI, Nielsen GG, Andersen PK, Teasdale TW. Genetic and environmental influences on premature death in adult adoptees. N Engl J Med. 1988;318(12):727-732
5. Arcaroli J, Fessler MB, Abraham E. Genetic polymorphisms and sepsis. Shock. 2005; 24(4):300-312
6. Waterer GW, Wunderink RG. Science review: genetic variability in the systemic inflammatory response. Crit Care. 2003;7(4): 308-314 (Pubitemid 36939550)
7. Holmes CL, Russell JA, Walley KR. Genetic polymorphisms in sepsis and septic shock: role in prognosis and potential for therapy. Chest. 2003;124(3):1103-1115
8. Stüber F, Klaschik S, Lehmann LE, Schewe JC, Weber S, Book M. Cytokine promoter polymorphisms in severe sepsis. Clin Infect Dis. 2005;41(suppl 7):S416-S420
9. Barber RC, Chang LY, Arnoldo BD, et al. Innate immunity SNPs are associated with risk for severe sepsis after burn injury. Clin Med Res. 2006;4(4):250-255
10. Bone RC. Sepsis and coagulation: an important link. Chest. 1992;101(3):594-596
11. Deitch EA. Animal models of sepsis and shock: a review and lessons learned. Shock. 1998;9(1):1-11
12. Flierl MA, Schreiber H, Huber-Lang MS. The role of complement, C5a and its receptors in sepsis and multiorgan dysfunction syndrome. J Invest Surg. 2006;19(4):255-265
13. Funk DJ, Parrillo JE, Kumar A. Sepsis and septic shock: a history. Crit Care Clin. 2009; 25(1):83-101, viii
14. Oberholzer A, Oberholzer C, Moldawer LL. Sepsis syndromes: understanding the role of innate and acquired immunity. Shock. 2001;16(2):83-96 (Pubitemid 33596740)
15. Weighardt H, Holzmann B. Role of Toll-like receptor responses for sepsis pathogenesis. Immunobiology. 2007;212(9-10): 715-722
16. Arbour NC, Lorenz E, Schutte BC, et al. TLR4 mutations are associated with endotoxin hyporesponsiveness in humans. Nat Genet. 2000;25(2):187-191 (Pubitemid 30394990)
17. Schwartz DA. The role of TLR4 in endotoxin responsiveness in humans. J Endotoxin Res. 2001;7(5):389-393
18. Lorenz E, Mira JP, Frees KL, Schwartz DA. Relevance of mutations in the TLR4 receptor in patients with gram-negative septic shock. Arch Intern Med. 2002;162(9): 1028-1032 (Pubitemid 34492532)
19. Agnese DM, Calvano JE, Hahm SJ, et al. Human Toll-like receptor 4 mutations but not CD14 polymorphisms are associated with an increased risk of gram-negative infections. J Infect Dis. 2002;186(10):1522-1525
20. Karoly E, Fekete A, Banki NF, et al. Heat shock protein 72 (HSPA1B) gene polymorphism and Toll-like receptor (TLR) 4 mutation are associated with increased risk of urinary tract infection in children. Pediatr Res. 2007;61(3):371-374
21. Read RC, Pullin J, Gregory S, et al. A functional polymorphism of Toll-like receptor 4 is not associated with likelihood or severity of meningococcal disease. J Infect Dis. 2001; 184(5):640-642 (Pubitemid 32783557)
22. Allen A, Obaro S, Bojang K, et al. Variation in Toll-like receptor 4 and susceptibility to group A meningococcal meningitis in Gambian children. Pediatr Infect Dis J. 2003; 22(11):1018-1019 (Pubitemid 37445083)
23. Hubacek JA, Stüber F, Fröhlich D, et al. The common functional C(-159)T polymorphism within the promoter region of the lipopolysaccharide receptor CD14 is not associated with sepsis development or mortality. Genes Immun. 2000;1(6):405-407
24. Gibot S, Cariou A, Drouet L, Rossignol M, Ripoll L. Association between a genomic polymorphism within the CD14 locus and septic shock susceptibility and mortality rate. Crit Care Med. 2002;30(5):969-973 (Pubitemid 34508015)
25. Heesen M, Bloemeke B, Schade U, Obertacke U, Majetschak M. The-260 C→T promoter polymorphism of the lipopolysaccharide receptor CD14 and severe sepsis in trauma patients. Intensive Care Med. 2002;28(8): 1161-1163 (Pubitemid 34985244)
26. Gu W, Shan YA, Zhou J, et al. Functional significance of gene polymorphisms in the promoter of myeloid differentiation-2. Ann Surg. 2007;246(1):151-158
27. Kutukculer N, Yeniay BS, Aksu G, Berdeli A. Arg753Gln polymorphism of the human Toll-like receptor-2 gene in children with recurrent febrile infections. Biochem Genet. 2007; 45(7-8):507-514
28. Tabel Y, Berdeli A, Mir S. Association of TLR2 gene Arg753Gln polymorphism with urinary tract infection in children. Int J Immuno-genet. 2007;34(6):399-405
29. Lorenz E, Mira JP, Cornish KL, Arbour NC, Schwartz DA. A novel polymorphism in the Toll-like receptor 2 gene and its potential association with staphylococcal infection. Infect Immun. 2000;68(11):6398-6401
30. van Deventer SJ. Cytokine and cytokine receptor polymorphisms in infectious disease. Intensive Care Med. 2000;26(suppl 1): S98-S102
31. Mira JP, Cariou A, Grall F, et al. Association of TNF2, a TNF-alpha promoter polymorphism, with septic shock susceptibility and mortality: a multicenter study. JAMA. 1999; 282(6):561-568
32. Nadel S, Newport MJ, Booy R, Levin M. Variation in the tumor necrosis factor-alpha gene promoter region may be associated with death from meningococcal disease. J Infect Dis. 1996;174(4):878-880 (Pubitemid 26325913)
33. McArthur JA, Zhang Q, Quasney MW. Association between the A/A genotype at the lymphotoxin-alpha+250 site and increased mortality in children with positive blood cultures. Pediatr Crit Care Med. 2002;3(4): 341-344
34. Read RC, Cannings C, Naylor SC, et al. Variation within genes encoding interleukin-1 and the interleukin-1 receptor antagonist influence the severity of meningococcal disease. Ann Intern Med. 2003;138(7):534-541
35. Endler G, Marculescu R, Starkl P, et al. Polymorphisms in the interleukin-1 gene cluster in children and young adults with systemic meningococcemia. Clin Chem. 2006;52(3): 511-514 (Pubitemid 43306477)
36. Lehrnbecher T, Bernig T, Hanisch M, et al. Common genetic variants in the interleukin-6 and chitotriosidase genes are associated with the risk for serious infection in children undergoing therapy for acute myeloid leukemia. Leukemia. 2005; 19(10):1745-1750 (Pubitemid 41486151)
37. Michalek J, Svetlikova P, Fedora M, et al. Interleukin-6 gene variants and the risk of sepsis development in children. Hum Immunol. 2007;68(9):756-760 (Pubitemid 47379980)
38. Balding J, Healy CM, Livingstone WJ, et al. Genomic polymorphic profiles in an Irish population with meningococcaemia: is it possible to predict severity and outcome of disease? Genes Immun. 2003;4(8):533-540
39. Artifoni L, Negrisolo S, Montini G, et al. Interleukin-8 and CXCR1 receptor functional polymorphisms and susceptibility to acute pyelonephritis. J Urol. 2007;177(3): 1102-1106
40. Westendorp RG, Hottenga JJ, Slagboom PE. Variation in plasminogen-activator-inhibitor- 1 gene and risk of meningococcal septic shock. Lancet. 1999;354(9178): 561-563
41. Haralambous E, Hibberd ML, Hermans PW, Ninis N, Nadel S, Levin M. Role of functional plasminogen-activator-inhibitor-1 4G/5G promoter polymorphism in susceptibility, severity, and outcome of meningococcal disease in Caucasian children. Crit Care Med. 2003;31(12):2788-2793
42. Geishofer G, Binder A, Muller M, et al. 4G/5G promoter polymorphism in the plasminogen-activator-inhibitor-1 gene in children with systemic meningococcaemia. Eur J Pediatr. 2005;164(8):486-490
43. Hermans PW, Hibberd ML, Booy R, et al. 4G/5G promoter polymorphism in the plasminogen-activator-inhibitor-1 gene and outcome of meningococcal disease. Meningococcal Research Group. Lancet. 1999; 354(9178):556-560
44. Binder A, Endler G, Rieger S, et al. Protein C promoter polymorphisms associate with sepsis in children with systemic meningococcemia. Hum Genet. 2007;122(2):183-190
45. van Sorge NM, van der Pol WL, van de Winkel JG. FcgammaR polymorphisms: implications for function, disease susceptibility and immunotherapy. Tissue Antigens. 2003; 61(3):189-202
46. Bredius RG, Derkx BH, Fijen CA, et al. Fc gamma receptor IIa (CD32) polymorphism in fulminant meningococcal septic shock in children. J Infect Dis. 1994; 170(4):848-853
47. Domingo P, Muniz-Diaz E, Baraldes MA, et al. Associations between Fc gamma receptor IIA polymorphisms and the risk and prognosis of meningococcal disease. Am J Med. 2002;112(1):19-25
48. Platonov AE, Kuijper EJ, Vershinina IV, et al. Meningococcal disease and polymorphism of FcgammaRIIa (CD32) in late complement component-deficient individuals. Clin Exp Immunol. 1998;111(1):97-101
49. Drogari-Apiranthitou M, Fijen CA, Thiel S, et al. The effect of mannan-binding lectin on opsonophagocytosis of Neisseria meningitidis. Immunopharmacology. 1997;38(1-2): 93-99
50. van der Pol WL, Huizinga TW, Vidarsson G, et al. Relevance of Fcgamma receptor and interleukin-10 polymorphisms for meningococcal disease. J Infect Dis. 2001;184(12): 1548-1555
51. Fijen CA, Bredius RG, Kuijper EJ. Polymorphism of IgG Fc receptors in meningococcal disease. Ann Intern Med. 1993;119(7 pt 1): 636
52. Michalek J, Svetlikova P, Fedora M, et al. Bactericidal permeability increasing protein gene variants in children with sepsis. Intensive Care Med. 2007;33(12):2158-2164 (Pubitemid 350164567)
53. Stalets E, Wong HR. Critically associating. Crit Care Med. 2009;37(4):1492-1493
54. Cooper DN, Nussbaum RL, Krawczak M. Proposed guidelines for papers describing DNA polymorphism-disease associations. Hum Genet. 2002;110(3):207-208
55. Wong HR, Shanley TP, Sakthivel B, et al; Genomics of Pediatric SIRS/Septic Shock Investigators. Genome-level expression profiles in pediatric septic shock indicate a role for altered zinc homeostasis in poor outcome. Physiol Genomics. 2007;30(2): 146-155
56. Rink L, Haase H. Zinc homeostasis and immunity. Trends Immunol. 2007;28(1):1-4
57. Knoell DL, Julian MW, Bao S, et al. Zinc deficiency increases organ damage and mortality in a murine model of polymicrobial sepsis. Crit Care Med. 2009;37(4): 1380-1388
58. Shanley TP, Cvijanovich N, Lin R, et al. Genome-level longitudinal expression of signaling pathways and gene networks in pediatric septic shock. Mol Med. 2007; 13(9-10):495-508
59. Ayala A, Chaudry IH. Immune dysfunction in murine polymicrobial sepsis: mediators, macrophages, lymphocytes and apoptosis. Shock. 1996;6(suppl 1):S27-S38
60. Felmet KA, Hall MW, Clark RS, Jaffe R, Carcillo JA. Prolonged lymphopenia, lymphoid depletion, and hypoprolactinemia in children with nosocomial sepsis and multiple organ failure. J Immunol. 2005;174(6): 3765-3772
61. Hotchkiss RS, Swanson PE, Knudson CM, et al. Overexpression of Bcl-2 in transgenic mice decreases apoptosis and improves survival in sepsis. J Immunol. 1999;162(7): 4148-4156
62. Hotchkiss RS, Swanson PE, Freeman BD, et al. Apoptotic cell death in patients with sepsis, shock, and multiple organ dysfunction. Crit Care Med. 1999;27(7):1230-1251
63. Hotchkiss RS, Tinsley KW, Karl IE. Role of apoptotic cell death in sepsis. Scand J Infect Dis. 2003;35(9):585-592
64. Hotchkiss RS, Karl IE. The pathophysiology and treatment of sepsis. N Engl J Med. 2003; 348(2):138-150
65. Hotchkiss RS, Coopersmith CM, Karl IE. Prevention of lymphocyte apoptosis: a potential treatment of sepsis? Clin Infect Dis. 2005; 41(suppl 7):S465-S469
66. Hotchkiss RS, Osmon SB, Chang KC, Wagner TH, Coopersmith CM, Karl IE. Accelerated lymphocyte death in sepsis occurs by both the death receptor and mitochondrial pathways. J Immunol. 2005;174(8): 5110-5118
67. Hotchkiss RS, McConnell KW, Bullok K, et al. TAT-BH4 and TAT-Bcl-xL peptides protect against sepsis-induced lymphocyte apoptosis in vivo. J Immunol. 2006;176(9): 5471-5477
68. Cvijanovich N, Shanley TP, Lin R, et al. Validating the genomic signature of pediatric septic shock. Physiol Genomics. 2008;34(1): 127-134
69. Pachot A, Cazalis MA, Venet F, et al. Decreased expression of the fractalkine receptor CX3CR1 on circulating monocytes as new feature of sepsis-induced immunosuppression. J Immunol. 2008;180(9): 6421-6429
70. Pachot A, Lepape A, Vey S, Bienvenu J, Mougin B, Monneret G. Systemic transcriptional analysis in survivor and non-survivor septic shock patients: a preliminary study. Immunol Lett. 2006;106(1):63-71
71. Tang BM, McLean AS, Dawes IW, Huang SJ, Lin RC. The use of gene-expression profiling to identify candidate genes in human sepsis. Am J Respir Crit Care Med. 2007;176(7): 676-684
72. Tang BM, McLean AS, Dawes IW, Huang SJ, Lin RC. Gene-expression profiling of peripheral blood mononuclear cells in sepsis. Crit Care Med. 2009;37(3):882-888
73. Wong HR, Cvijanovich N, Allen GL, et al. Genomic expression profiling across the pediatric systemic inflammatory response syndrome, sepsis, and septic shock spectrum. Crit Care Med. 2009;37(5):1558-1566
74. Wong HR, Cvijanovich N, Lin R, et al. Identification of pediatric septic shock subclasses based on genome-wide expression profiling. BMC Med. 2009;7:34
75. Berger SL, Kouzarides T, Shiekhattar R, Shilatifard A. An operational definition of epigenetics. Genes Dev. 2009;23(7):781-783
76. Jenuwein T, Allis CD. Translating the histone code. Science. 2001;293(5532):1074-1080
77. Reik W. Stability and flexibility of epigenetic gene regulation in mammalian development. Nature. 2007;447(7143):425-432
78. Wysocka J, Swigut T, Milne TA, et al. WDR5 associates with histone H3 methylated at K4 and is essential for H3 K4 methylation and vertebrate development. Cell. 2005;121(6): 859-872
79. Cao S, Fernandez-Zapico ME, Jin D, et al. KLF11-mediated repression antagonizes Sp1/sterol-responsive element-binding protein-induced transcriptional activation of caveolin-1 in response to cholesterol signaling. J Biol Chem. 2005;280(3):1901-1910
80. Dou Y, Milne TA, Ruthenburg AJ, et al. Regulation of MLL1 H3K4 methyltransferase activity by its core components. Nat Struct Mol Biol. 2006;13(8):713-719
81. Su RC, Becker AB, Kozyrskyj AL, Hayglass KT. Epigenetic regulation of established human type 1 versus type 2 cytokine responses. J Allergy Clin Immunol. 2008;121(1): 57.e3-63.e3
82. Wen H, Dou Y, Hogaboam CM, Kunkel SL. Epigenetic regulation of dendritic cell-derived interleukin-12 facilitates immunosuppression after a severe innate immune response. Blood. 2008;111(4):1797-1804
83. Ishii M, Wen H, Corsa CA, et al. Epigenetic regulation of the alternatively activated macrophage phenotype. Blood. 2009; 114(15):3244-3254
84. Marshall JC. Sepsis: rethinking the approach to clinical research. J Leukoc Biol. 2008;83(3):471-482
85. Osuchowski MF, Connett J, Welch K, Granger J, Remick DG. Stratification is the key: inflammatory biomarkers accurately direct immunomodulatory therapy in experimental sepsis. Crit Care Med. 2009;37(5): 1567-1573
86. Warren HS, Elson CM, Hayden DL, et al. A genomic score prognostic of outcome in trauma patients. Mol Med. 2009;15(7-8): 220-227
87. Wong HR, Cvijanovich N, Wheeler DS, et al. Interleukin-8 as a stratification tool for interventional trials involving pediatric septic shock. Am J Respir Crit Care Med. 2008; 178(3):276-282
88. Nowak JE, Wheeler DS, Harmon KK, Wong HR. Admission chemokine (C-C motif) ligand 4 levels predict survival in pediatric septic shock. Pediatr Crit Care Med. 2010;11(2): 213-216